Literature DB >> 7527322

Optimum outpatient therapy of skin and skin structure infections.

D M Failla1, G A Pankey.   

Abstract

Skin and skin structure infections appear in a variety of ways with multiple aetiologies. Optimum therapy is accomplished with a good understanding of both skin anatomy and common resident or transient bacterial flora present on the skin surface. Primary and secondary infections occur in both immunocompetent and immunocompromised patients, each of which require unique decision-making skills on the part of the prescriber. Deciding when culture and sensitivity should be performed or therapy should be begun empirically is often difficult and can be frustrating. This is complicated by the ever-increasing number of antimicrobial agents available today and their variable costs. Choosing the best antibiotic agent, based on evidence of which is the most effective agent for a particular lesion, the easiest dosage schedule and the most economical drug, is a goal that will best serve both the patient and the physician.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527322     DOI: 10.2165/00003495-199448020-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  5 in total

Review 1.  Common bacterial skin infections. Diagnostic clues and therapeutic options.

Authors:  R M Kahn; E J Goldstein
Journal:  Postgrad Med       Date:  1993-05-01       Impact factor: 3.840

Review 2.  Antimicrobial therapy of skin and soft tissue infection in children.

Authors:  I Brook
Journal:  J Am Podiatr Med Assoc       Date:  1993-07

Review 3.  Diagnosis and management of the diabetic foot ulcer.

Authors:  L O Gentry
Journal:  J Antimicrob Chemother       Date:  1993-07       Impact factor: 5.790

Review 4.  Microbial ecology of the skin.

Authors:  R R Roth; W D James
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

5.  Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.

Authors:  G A Pankey; H P Katner; G T Valainis; M J Clarkson; L M Cortez; J R Dalovisio
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

  5 in total
  2 in total

1.  Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Authors:  G Siami; N Christou; I Eiseman; K J Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 2.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.